Eruptive penile mucosal pyogenic granulomas associated with amivantamab-based therapy: report of two cases
Clinical and Experimental Dermatology · 13.11.2026
DOI: 10.1093/ced/llag477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 13.11.2026. Verfasst von Pablo Fernández Fernández und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
Abstract (Originalsprache)
We report two cases of eruptive pyogenic granulomas involving the penile mucosa in patients receiving amivantamab therapy for metastatic non-small cell lung cancer. Recognition of this distinctive mucocutaneous toxicity may help avoid unnecessary investigations and inappropriate interruption of oncologic treatment.
Autor:innen und Institutionen
- Department of Dermatology, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
- Department of Anatomic Pathology, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
- Department of Dermatology, Hospital Universitario Clínico San Carlos, Madrid, Spain.
ORCID-Profile: Pablo Fernández Fernández
Zitieren
APA
Fernández Fernández, P., Felices López, B., Santos-Briz, Á., Agud De Dios, M., Baeza-Hernández, G., & Cañueto, J. (2026). Eruptive penile mucosal pyogenic granulomas associated with amivantamab-based therapy: report of two cases. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag477
Vancouver
Fernández Fernández P, Felices López B, Santos-Briz Á, Agud De Dios M, Baeza-Hernández G, Cañueto J. Eruptive penile mucosal pyogenic granulomas associated with amivantamab-based therapy: report of two cases. Clinical and Experimental Dermatology. 2026. doi:10.1093/ced/llag477
BibTeX
@article{FernndezFernndez2026,
author = {Fernández Fernández, Pablo and Felices López, Borja and Santos-Briz, Ángel and Agud De Dios, Manuel and Baeza-Hernández, Gloria and Cañueto, Javier},
title = {Eruptive penile mucosal pyogenic granulomas associated with amivantamab-based therapy: report of two cases},
journal = {Clinical and Experimental Dermatology},
year = {2026},
doi = {10.1093/ced/llag477}
}
EUVIMED